ketoconazole has been researched along with Hand Dermatosis in 31 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have treated 48 cases of onychomycosis (of which 37 were caused by dermatophytes, 10 by yeasts and one by Scopulariopsis brevicaulis) with 200 mg ketoconazole daily." | 7.67 | [Ketoconazole and onychomycosis]. ( Achten, G; André, J; Parent, D; Wiame, L, 1984) |
| "A case of monilial granuloma of 12 years duration is being successfully treated with ketoconazole administered orally in doses of 200 mg per day." | 7.67 | [Monilial granuloma treated successfully with ketoconazole over a period of 30 months]. ( Deschamps, P; Leroy, D; Mahoudeau, J; Michel, M; Vion, M, 1984) |
| "An economic analysis of the oral antifungal drugs griseofulvin (GRI), ketoconazole (KET), and terbinafine (TER), currently registered and used in treating onychomycosis of fingernails and toenails, was performed using a model that incorporates elements of both meta-analysis and pharmacoeconomics." | 4.79 | Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective. ( Arikian, SR; Einarson, TR; Shear, NH, 1994) |
| " We conducted a multinational cost-effectiveness analysis, from a government payer perspective, comparing four primary oral treatment regimens for onychomycosis of the fingernails and toenails: griseofulvin, itraconazole, ketoconazole and terbinafine." | 4.79 | A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group. ( Arikian, SR; Einarson, TR; Kobelt-Nguyen, G; Schubert, F, 1994) |
| "We have treated 48 cases of onychomycosis (of which 37 were caused by dermatophytes, 10 by yeasts and one by Scopulariopsis brevicaulis) with 200 mg ketoconazole daily." | 3.67 | [Ketoconazole and onychomycosis]. ( Achten, G; André, J; Parent, D; Wiame, L, 1984) |
| "A case of monilial granuloma of 12 years duration is being successfully treated with ketoconazole administered orally in doses of 200 mg per day." | 3.67 | [Monilial granuloma treated successfully with ketoconazole over a period of 30 months]. ( Deschamps, P; Leroy, D; Mahoudeau, J; Michel, M; Vion, M, 1984) |
| "On further follow up, recurrence of onychomycosis was recorded in two patients in group I." | 2.73 | Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. ( Bansal, S; Grover, C; Kumar, V; Nanda, S; Reddy, BS, 2007) |
| " In addition, the short treatment times (< 3 months) and intermittent dosing schedules are likely to enhance compliance and reduce the costs of therapy." | 2.40 | Onychomycosis: pathogenesis, diagnosis, and management. ( Elewski, BE, 1998) |
| "The management of onychomycosis has changed considerably in the past few years." | 2.38 | Onychomycosis. Agents of choice. ( Hay, RJ, 1993) |
| "Ketoconazole is an alternative when a replacement for griseofulvin is required, provided the degree of disability justifies the risk of drug toxicity." | 1.27 | Long-term ketoconazole treatment of chronic acral dermatophyte infections. ( Hersle, K; Mobacken, H; Moberg, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (51.61) | 18.7374 |
| 1990's | 9 (29.03) | 18.2507 |
| 2000's | 4 (12.90) | 29.6817 |
| 2010's | 2 (6.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maia Abinader, MV | 1 |
| Carvalho Maron, SM | 1 |
| Araújo, LO | 1 |
| Silva, Ado A | 1 |
| Zhao, Y | 1 |
| Li, L | 1 |
| Wang, JJ | 1 |
| Kang, KF | 1 |
| Zhang, QQ | 1 |
| Figueiredo, VT | 1 |
| de Assis Santos, D | 1 |
| Resende, MA | 1 |
| Hamdan, JS | 1 |
| Grover, C | 1 |
| Bansal, S | 1 |
| Nanda, S | 1 |
| Reddy, BS | 1 |
| Kumar, V | 1 |
| Joubert, M | 1 |
| Bravard, P | 1 |
| Reznik, Y | 1 |
| Parent, D | 1 |
| Achten, G | 1 |
| André, J | 1 |
| Wiame, L | 1 |
| van Ketel, WG | 1 |
| Watanabe, S | 1 |
| Shimozuma, M | 1 |
| Takizawa, K | 1 |
| Leroy, D | 1 |
| Michel, M | 1 |
| Vion, M | 1 |
| Mahoudeau, J | 1 |
| Deschamps, P | 1 |
| Crozier, WJ | 1 |
| Wise, KA | 1 |
| Einarson, TR | 2 |
| Arikian, SR | 2 |
| Shear, NH | 1 |
| Kobelt-Nguyen, G | 1 |
| Schubert, F | 1 |
| Hay, RJ | 3 |
| Desgarennes, MD | 1 |
| Godoy, MR | 1 |
| Palencia, AB | 1 |
| Elewski, BE | 1 |
| Tomimori-Yamashita, J | 1 |
| Ogawa, MM | 1 |
| Hirata, SH | 1 |
| Fischman, O | 1 |
| Michalany, NS | 1 |
| Yamashita, HK | 1 |
| Alchorne, M | 1 |
| Baran, R | 1 |
| Clayton, YM | 2 |
| Moore, MK | 2 |
| Midgely, G | 2 |
| Coldiron, BM | 1 |
| Wiley, EL | 1 |
| Rinaldi, MG | 1 |
| Belukha, UK | 1 |
| Bidrat, MS | 1 |
| Luk'ianova, AS | 1 |
| Leshchenko, VM | 1 |
| Kukoleva, LI | 1 |
| Shirshikova, IuI | 1 |
| Rukavishnikova, VM | 1 |
| Dadiomova, VG | 1 |
| Bourrel, P | 1 |
| Andreu, JM | 1 |
| Cazenave, JC | 1 |
| Van Hecke, E | 1 |
| Van Cutsem, J | 1 |
| Zaias, N | 1 |
| Török, I | 1 |
| Stehlich, G | 1 |
| Stepanova, ZhV | 1 |
| Smol'iakova, LL | 1 |
| Nilsen, A | 1 |
| Høvding, G | 1 |
| Hersle, K | 1 |
| Mobacken, H | 1 |
| Moberg, S | 1 |
| Zschunke, E | 1 |
| Seebacher, C | 1 |
| Schuppli, R | 1 |
4 reviews available for ketoconazole and Hand Dermatosis
| Article | Year |
|---|---|
Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective.
Topics: Antifungal Agents; Canada; Cost-Benefit Analysis; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Hu | 1994 |
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Foot Dermatoses; Griseofulvin | 1994 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconaz | 1993 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand | 1998 |
4 trials available for ketoconazole and Hand Dermatosis
| Article | Year |
|---|---|
Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bandages; Child; Combined Modality Therapy; Drug Adminis | 2007 |
Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Hand Dermatos | 1988 |
[Experience with nizoral treatment of patients with rubromycosis].
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Hand Dermatoses; Humans; Ketoconazole; Male; Mi | 1988 |
[Ketoconazole in onychomycosis].
Topics: Adult; Clinical Trials as Topic; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans | 1985 |
23 other studies available for ketoconazole and Hand Dermatosis
| Article | Year |
|---|---|
Tinea nigra dermoscopy: A useful assessment.
Topics: Administration, Topical; Adolescent; Antifungal Agents; Cladosporium; Dermoscopy; Hand Dermatoses; H | 2016 |
Cutaneous malasseziasis: four case reports of atypical dermatitis and onychomycosis caused by Malassezia.
Topics: Administration, Topical; Adult; Biopsy, Needle; Child, Preschool; Dermatomycoses; Female; Follow-Up | 2010 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; I | 2007 |
'Anti-cortisolic' treatment of warts.
Topics: Adult; Hand Dermatoses; Humans; Hydrocortisone; Ketoconazole; Male; Pituitary ACTH Hypersecretion; W | 2008 |
[Ketoconazole and onychomycosis].
Topics: Adolescent; Adult; Aged; Arthrodermataceae; Candidiasis; Female; Foot Dermatoses; Hand Dermatoses; H | 1984 |
An allergic eruption probably caused by ketoconazole.
Topics: Adult; Antifungal Agents; Drug Eruptions; Female; Hand Dermatoses; Humans; Ketoconazole; Patch Tests | 1983 |
Superficial hyperkeratotic candidiasis on the palms and soles.
Topics: Candida; Candidiasis, Cutaneous; Foot Dermatoses; Hand Dermatoses; Humans; Ketoconazole; Male; Middl | 1983 |
[Monilial granuloma treated successfully with ketoconazole over a period of 30 months].
Topics: Adolescent; Candidiasis; Candidiasis, Chronic Mucocutaneous; Facial Dermatoses; Granuloma; Hand Derm | 1984 |
Onychomycosis due to Pityrosporum.
Topics: Adult; Aged; Chloroform; Female; Hand Dermatoses; Humans; Ketoconazole; Malassezia; Male; Miconazole | 1993 |
Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
Topics: Antifungal Agents; Child; Female; Griseofulvin; Hand Dermatoses; Humans; Ketoconazole; Microsporum; | 1996 |
Mycetoma caused by Fusarium solani with osteolytic lesions on the hand: case report.
Topics: Aged; Antifungal Agents; Fusarium; Hand; Hand Dermatoses; Humans; Ketoconazole; Male; Metacarpus; My | 2002 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; H | 1992 |
Itraconazole in the management of chronic dermatophytosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Administration Schedule; Femal | 1990 |
Cutaneous phaeohyphomycosis caused by a rare fungal pathogen, Hormonema dematioides: successful treatment with ketoconazole.
Topics: Dermatomycoses; Hand Dermatoses; Humans; Immune Tolerance; Ketoconazole; Male; Middle Aged; Mitospor | 1990 |
[A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
Topics: Biological Products; Blood Bactericidal Activity; Combined Modality Therapy; Foot Dermatoses; Griseo | 1989 |
[Experience in treating patients with rubrophytosis with nizoral].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; | 1989 |
[Mycetoma of the hand. Apropos of 10 cases].
Topics: Adolescent; Adult; Aged; Female; Hand Dermatoses; Humans; Ketoconazole; Male; Mycetoma; Preoperative | 1989 |
An evaluation of itraconazole in the management of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; Humans; I | 1988 |
Onychomycosis.
Topics: Adult; Candida albicans; Candidiasis, Chronic Mucocutaneous; Foot Dermatoses; Glutaral; Griseofulvin | 1985 |
Long term post-treatment follow-up of onychomycoses treated with ketoconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermato | 1986 |
Long-term ketoconazole treatment of chronic acral dermatophyte infections.
Topics: Female; Griseofulvin; Hand Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Onychomycosis; Recur | 1985 |
[Occupational yeast infection of the skin--an expert opinion].
Topics: Aged; Candidiasis, Cutaneous; Dentists; Dermatitis, Occupational; Germany, East; Hand Dermatoses; Hu | 1985 |
[Fungal infections of the hand].
Topics: Dermatomycoses; Griseofulvin; Hand Dermatoses; Humans; Ketoconazole | 1985 |